Selenium, zinc, and prostate cancer

Epidemiologic Reviews

Volumn 23, Issue 1, 2001, Pages 93-101

  Platz, Elizabeth A ^a   Helzlsouer, Kathy J ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SELENIUM; ZINC;

CANCER GROWTH; CANCER PREVENTION; CARCINOGENESIS; DIET; DRUG EFFICACY; HUMAN; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW;

EID: 0034801377     PISSN: 0193936X     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.epirev.a000801     Document Type: Review

References (92)

1. The nutritional biochemistry of selenium
2. False presumptions and continued surprises: How much do we really know about nutritional supplements and cancer risk?
3. Possible protective effect of selenium against human cancer
4. Selenium distribution and human cancer mortality
5. Antioxidants and cancer. Part VI. Selenium and age-adjusted human cancer mortality
6. Cancer mortality correlation studies-IV: Associations with dietary intakes and blood levels of certain trace elements, notably Se-antagonists
7. Cancer mortality correlation studies-III: Statistical associations with dietary selenium intakes
8. Selenium in forage crops and cancer mortality in US counties
9. The chemopreventive role of selenium in carcinogenesis
10. Involvement of polyamines in selenomethionine induced apoptosis and mitotic alterations in human tumor cells
11. Role of selenium in the chemoprevention of cancer
12. The diverse role of selenium within selenoproteins: A review
13. Differential expression and androgen regulation of the human selenium-binding protein gene hSP56 in prostate cancer cells
14. Inhibitory effect of selenomethionine on the growth of three selected human tumor cell lines
15. Selenium effects on prostate cell growth
16. Lack of modification by naturally occurring antioxidants of 3,2′-dimethyl-4-aminobiphenyl-initiated rat prostate carcinogenesis
17. Prooxidant-antioxidant shift induced by androgen treatment of human prostate carcinoma cells
18. Localization of antioxidant enzymes and oxidative damage products in normal and malignant prostate epithelium
19. Zinc, cadmium and selenium concentrations in separated epithelium and stroma from prostatic tissues of different histology
20. A new selenoprotein found in the glandular epithelial cells of the rat prostate
21. Adult dietary intake and prostate cancer risk in Utah: A case-control study with special emphasis on aggressive tumors
22. A case-control study of diet and prostate cancer
23. Case-control study of diet and prostate cancer in China
24. Plant foods, antioxidants, and prostate cancer risk: Findings from case-control studies in Canada
25. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin: A randomized controlled trial
26. Decreased incidence of prostate cancer with selenium supplementation: Results of a double-blind cancer prevention trial
27. Selenium and cancer prevention: Promising results indicate further trials required
28. Selenium supplementation and cancer rates
29. Selenium supplementation and cancer rates
30. Selenium supplementation and cancer rates
31. The association between baseline vitamin E, selenium, and prostate cancer in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study
32. Nutritional influence on cellular antioxidant defense systems
33. Human selenite metabolism: A kinetic model
34. Use of selenium concentration in whole blood, serum, toenails, or urine as a surrogate measure of selenium intake
35. A 1-y trial of the effect of high-selenium bread on selenium concentrations in blood and toenails
36. Toenail trace element levels as biomarkers: Reproducibility over a 6-year period
37. A study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer
38. Association between α-tocopherol, γ-tocopherol, selenium and subsequent prostate cancer
39. Prediagnostic serum selenium and risk of cancer
40. Serum levels of selenium and retinol and the subsequent risk of cancer
41. Serum selenium and subsequent risk of cancer among Finnish men and women
42. Selenium, retinol, retinol-binding protein, and uric acid: Associations with cancer mortality in a population-based prospective case-control study
43. Serum selenium and subsequent risk of prostate cancer
44. Levels of selenium in plasma and glutathione peroxidase in erythrocytes in patients with prostate cancer or benign hyperplasia
45. A case-control study of toenail selenium and cancer of the breast, colon, and prostate
46. Risk of cancer in relation to serum concentrations of selenium and vitamins A and E: Matched case-control analysis of prospective data
47. Comparison of the effects of an organic and an inorganic form of selenium on a mammary carcinoma cell line
48. Selenium and prostate cancer prevention
49. Relationship between serum selenium levels and patients with carcinoma
50. The role of dietary manipulation in biochemical recurrence of prostate cancer after radical prostatectomy
51. Selenium - Its biological perspectives
52. Cadmium and prostate cancer
53. Selenium prevents the growth stimulatory effects of cadmium on human prostatic epithelium
54. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers
55. Prostate cancer prevention trials in the USA
56. Toxic effects of metals
57. Plasma zinc and vitamin A in human squamous carcinoma of the esophagus
58. A case-control study of element levels and cancer of the upper aerodigestive tract
59. Influence of dietary factors on oral precancerous lesions in a population-based case-control study in Kerala, India
60. Serum copper and zinc and the risk of death from cancer and cardiovascular disease
61. A case-control study of oral cancer and pre-diagnostic concentrations of selenium and zinc in nail tissue
62. Prediagnostic serum selenium and zinc levels and subsequent risk of lung and stomach cancer in Japan
63. Nutrition intervention trials in Linxian, China: Supplementation with specific vitamin-mineral combinations, cancer incidence, and disease-specific mortality in the general population
64. Effects of vitamin/ mineral supplementation on the prevalence of histological dysplasia and early cancer of the esophagus and stomach: Results from the General Population Trial in Linxian, China
65. Intervention probable du zinc dans les phenomenes de fecondations chez les animaux vertebres
66. The occurrence of zinc in the human prostate gland
67. The distribution of zinc with the human prostate
68. Novel role of zinc in the regulation of prostate citrate metabolism and its implications in prostate cancer
69. Evidence for a zinc uptake transporter in human prostate cancer cells which is regulated by prolactin and testosterone
70. Zinc causes a shift toward citrate at equilibrium of the m-aconitase reaction of prostate mitochondria
71. The effect of zinc on the 5α-reduction of testosterone by the hyperplastic human prostate gland
72. Induction of necrosis by zinc in prostate carcinoma cells and identification of proteins increased in association with this induction
73. Inhibitory effect of zinc on human prostatic carcinoma cell growth
74. Zinc induced mitochondria apoptogenesis in prostate cells
75. Vitamin and mineral supplement use is associated with reduced risk of prostate cancer
76. Energy, nutrient intake and prostate cancer risk: A population-based case-control study in Sweden
77. Diet and prostatic cancer: A case-control study in Hawaii
78. Diet and prostate cancer: A case-control study
79. Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals
80. Zinc, vitamin A and prostatic cancer
81. Variations in zinc, calcium and magnesium in normal subjects and in patients with neoplasias
82. Zinc and cadmium concentrations in indigenous blacks with normal, hypertrophic, and malignant prostate
83. Zinc plasma levels in prostatic carcinoma and BPH
84. Metal-androgen interrelationships in carcinoma and hyperplasia of the human prostate
85. Zinc in the human prostate gland: Normal, hyperplastic and cancerous
86. Zinc and cadmium analysis in human prostate neoplasms
87. The zinc and copper content of blood leucocytes and plasma from patients with benign and malignant prostates
88. Zinc and cadmium plasma and erythrocyte levels in prostatic carcinoma, BPH, urological malignancies, and inflammations
89. Regulation of metallothionein gene expression by oxidative stress and metal ions
90. Biochemical indicators of dietary intake